Homeopathic company refuses to recall life-threatening nasal spray, FDA says

Quick Summary:

But, instead of discarding the batch, FDA inspectors found evidence that Green Pharmaceuticals had repackaged some of the contaminated lot and distributed it as single spray bottles or as part of a starter kit.

The FDA highlighted the risk to people with compromised immune systems and also children, since SnoreStop is marketed to kids as young as age 5.

According to the regulator, an FDA inspection in April uncovered laboratory test results showing that a batch of SnoreStop contained "significant microbial contamination".

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Author / Journalist: Beth Mole

Category: Technology

Markets: United States

Topics: Homeopathy Science Snorestop Nasal spray Fda

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-09-19 @ 18:40:11 (1 weeks ago)

News Timezone: GMT -5:00

News Source URL: arstechnica.com

Language: English

Article Length: 147 words

Reading Time: 1 minutes read

Sentences: 36 lines

Sentence Length: 5 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Ars Technica

News ID: 22606023

View Article Analysis

About Ars Technica

Main Topics: Technology

Official Website: arstechnica.com

Update Frequency: 15 posts per day

Year Established: 1998

Headquarters: United States

News Last Updated: 17 hours ago

Coverage Areas: United States

Ownership: Independent Company

Publication Timezone: GMT -5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #32

Publisher Details

Frequently Asked Questions